BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14575700)

  • 1. Photofrin as a radiosensitizer in an in vitro cell survival assay.
    Kulka U; Schaffer M; Siefert A; Schaffer PM; Olsner A; Kasseb K; Hofstetter A; Dühmke E; Jori G
    Biochem Biophys Res Commun; 2003 Nov; 311(1):98-103. PubMed ID: 14575700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photofrin II as an efficient radiosensitizing agent in an experimental tumor.
    Schaffer M; Schaffer PM; Corti L; Sotti G; Hofstetter A; Jori G; Dühmke E
    Onkologie; 2001 Oct; 24(5):482-5. PubMed ID: 11694776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation therapy combined with photofrin or 5-ALA: effect on Lewis sarcoma tumor lines implanted in mice. Preliminary results.
    Schaffer M; Schaffer PM; Jori G; Corti L; Sotti G; Hofstetter A; Dühmke E
    Tumori; 2002; 88(5):407-10. PubMed ID: 12487560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photofrin as a specific radiosensitizing agent for tumors: studies in comparison to other porphyrins, in an experimental in vivo model.
    Schaffer M; Schaffer PM; Corti L; Gardiman M; Sotti G; Hofstetter A; Jori G; Dühmke E
    J Photochem Photobiol B; 2002 Apr; 66(3):157-64. PubMed ID: 11960724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Application of Photofrin II as a sensitizing agent for ionizing radiation--a new approach in tumor therapy?
    Schaffer M; Ertl-Wagner B; Schaffer PM; Kulka U; Jori G; Dühmke E; Hofstetter A
    Curr Med Chem; 2005; 12(10):1209-15. PubMed ID: 15892632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell survival characteristics of a human colon adenocarcinoma cell line after photodynamic treatment: a comparison of Photofrin II and TPPS.
    West CM; Moore JV
    Int J Radiat Biol; 1988 Oct; 54(4):621-34. PubMed ID: 2902160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Photofrin II as a specific radiosensitising agent in patients with bladder cancer--a report of two cases.
    Schaffer M; Schaffer PM; Vogesser M; Ertl-Wagner B; Rauch J; Oberneder R; Jori G; Hofstetter A; Dühmke E
    Photochem Photobiol Sci; 2002 Sep; 1(9):686-9. PubMed ID: 12665306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photofrin based photodynamic therapy and miR-99a transfection inhibited FGFR3 and PI3K/Akt signaling mechanisms to control growth of human glioblastoma In vitro and in vivo.
    Chakrabarti M; Banik NL; Ray SK
    PLoS One; 2013; 8(2):e55652. PubMed ID: 23409016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The photodynamic effects of photofrin II, hematoporphyrin derivative, hematoporphyrin, and tetrasodium-mesotetra(4-sulfonatophenyl)porphine in vitro: clonogenic cell survival and drug uptake studies.
    West CM; Moore JV
    Photochem Photobiol; 1989 Feb; 49(2):169-74. PubMed ID: 2523543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of photofrin II and light energy on retinoblastoma-like cells in vitro. Dose-response relationships, effect of light dose rate and recovery ratio.
    Winther J
    J Cancer Res Clin Oncol; 1989; 115(1):73-8. PubMed ID: 2522095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the double role of photofrin as a photo- and a radio-sensitising agent: a possible new combination therapy for tumours.
    Schaffer M; Schaffer PM; Hofstetter A; Dühmke E; Jori G
    Photochem Photobiol Sci; 2002 Jun; 1(6):438-9. PubMed ID: 12856714
    [No Abstract]   [Full Text] [Related]  

  • 12. Oxidative modification induced by photodynamic therapy with Photofrin®II and 2-methoxyestradiol in human ovarian clear carcinoma (OvBH-1) and human breast adenocarcinoma (MCF-7) cells.
    Saczko J; Choromańska A; Rembiałkowska N; Dubińska-Magiera M; Bednarz-Misa I; Bar J; Marcinkowska A; Kulbacka J
    Biomed Pharmacother; 2015 Apr; 71():30-6. PubMed ID: 25960212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
    Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of Photofrin-mediated photodynamic therapy on the modulation of EGFR in esophageal squamous cell carcinoma cells.
    Yang PW; Hung MC; Hsieh CY; Tung EC; Wang YH; Tsai JC; Lee JM
    Lasers Med Sci; 2013 Feb; 28(2):605-14. PubMed ID: 22585382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial ablation by means of photodynamic therapy with photofrin II.
    Bhatta N; Anderson RR; Flotte T; Schiff I; Hasan T; Nishioka NS
    Am J Obstet Gynecol; 1992 Dec; 167(6):1856-63. PubMed ID: 1471710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photobleaching kinetics of Photofrin in vivo and in multicell tumour spheroids indicate two simultaneous bleaching mechanisms.
    Finlay JC; Mitra S; Patterson MS; Foster TH
    Phys Med Biol; 2004 Nov; 49(21):4837-60. PubMed ID: 15584523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro.
    Dysart JS; Patterson MS
    Phys Med Biol; 2005 Jun; 50(11):2597-616. PubMed ID: 15901957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of astrocytoma grade III with Photofrin II as a radiosensitizer. A case report.
    Schaffer M; Hofstetter A; Ertl-Wagner B; Batash R; Pöschl J; Schaffer PM
    Strahlenther Onkol; 2013 Nov; 189(11):972-6. PubMed ID: 24158603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cervix carcinoma FIGO IIIb with Photofrin II as a radiosensitizer: a case report.
    Schaffer P; Batash R; Ertl-Wagner B; Hofstetter A; Asna N; Schaffer M
    Photochem Photobiol Sci; 2019 May; 18(5):1275-1279. PubMed ID: 30892313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic effects of porphyrin and chlorin photosensitizers in human colon adenocarcinoma cells.
    Banfi S; Caruso E; Caprioli S; Mazzagatti L; Canti G; Ravizza R; Gariboldi M; Monti E
    Bioorg Med Chem; 2004 Sep; 12(18):4853-60. PubMed ID: 15336264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.